Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia. 1995

M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
Heinrich-Heine-University Medical Center, Department of Haematology, Oncology and Clinical Immunology, Düsseldorf, Germany.

Pulmonary toxicity with acute dyspnea occurred during infusion of a liposomal amphotericin B preparation (AmBisome) in two adult leukemic patients. The preparation was administered as a one hour infusion at a dose of 3 mg/kg body weight. Within 15 min after starting the infusion, both patients experienced sudden onset of dyspnea and chest tightness. Physical examination showed the patients to be anxious and restless with tachycardia and orthopnea but without other cardiopulmonary findings. No elevation of body temperature, rigors or chills were recorded. Symptoms disappeared within minutes after discontinuing the infusion. At present, the pathophysiologic mechanisms underlying these side effects are unknown.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
April 1991, Annals of internal medicine,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
October 2020, The Annals of pharmacotherapy,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
June 2002, Mycoses,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
February 2003, The Journal of antimicrobial chemotherapy,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
October 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
June 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
August 2002, Swiss medical weekly,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
February 2005, Journal of chemotherapy (Florence, Italy),
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
January 1985, Reviews of infectious diseases,
M Arning, and A H Heer-Sonderhoff, and A Wehmeier, and W Schneider
October 2014, Tropical doctor,
Copied contents to your clipboard!